Primary hemangiopericytoma in parietal bone: literature review and case report.

Xiao Xiao, Qiang Li, Yan Ju

Open access · greenAbstract readCase Reports

In one paragraph

Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 95% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Xiao XiaoSchool of Medicine, University of Electronic Science and Technology of China Chengdu 610054, Sichuan, P. R. China.

Qiang LiDepartment of Neurosurgery, West China Hospital of Sichuan University Chengdu 610041, Sichuan, P. R. China.

Yan JuDepartment of Neurosurgery, West China Hospital of Sichuan University Chengdu 610041, Sichuan, P. R. China.

Sichuan University · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemangiopericytoma (HPC) is a tumor originating from pericytes surrounding the capillary walls. Most HPCs grow slowly, but some display aggressive growth. Treatment for HPC is total resection or resection plus adjuvant radiation. CASE PRESENTATION: A 14-year-old girl presented with a blood vessel-rich tumor with a smooth surface located on the left side of the parietal bone, attached to the inner surface of the skull. The dura was completely intact. The final diagnosis was HPC based on the histopathologic and immunohistochemical findings. The patient underwent total resection of the tumor and cranioplasty. The dura was not incised because of the lack of invasive growth. Within the 2-year follow-up, the patient showed an excellent prognosis without any local recurrence or positive radiologic features.

conclusionThe patient presented with common intracranial hypertension symptoms. A blood vessel-rich tumor with a smooth surface was attached to the inner surface of the skull with the dura completely intact. Simple surgical resection without radiotherapy offered an excellent prognosis during 2 years of follow-up.

Indexed as

Hemangiopericytomaskull

Identifiers

PMID36915721

PMCPMC10006763

OpenAlexW4324129111

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.